Molecular Pharming Market to Reach USD 3.5 Billion by 2034, Driven by Demand for Cost-Effective Biologic Production

Molecular Pharming Market Size is valued at USD 1655.3 Mn in 2023 and is predicted to reach USD 3516.73 Mn by the year 2034 at a 8.1% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1712

Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Molecular Pharming market are:
• Rising Research in Bio-Farming
• Growing Demand for Cost-Effective, Scalable, And Fast Methods Of Producing Vaccines And Therapeutic Proteins
• Advantages Over traditional Methods of Protein Production

The following are the primary obstacles to the Molecular Pharming market's expansion:
• High Costs of Development and Scale-Up
• Risks of Contamination
• High Initial Investment Costs hamper Target Market Expansion

Future expansion opportunities for the global Molecular Pharming market include:
• Rising Demand for Biologics
• Rising Prevalence of Disease Indications
• Expansion into Nutraceuticals to Fuel Focused Market Growth Opportunity

Key Industry Insights & Findings from the report:
• North America is expected to have the largest market share in 2024 due to its sophisticated biopharmaceutical industry, significant R&D expenditures, and robust healthcare system, which allow for the regional commercialization of molecular pharmaceutics.
• Maize, a grain used to create recombinant proteins such as antibodies, hormones, and vaccines, is expected to dominate the market in the next years.
• Asia Pacific is expected to expand at the fastest rate due to significant success in applying modern agriculture methods.
• The rising prevalence of chronic illnesses and the need for new therapies are boosting demand for biopharmaceuticals, which molecular pharming can effectively create.

Market Analysis:
Molecular pharming, also referred to as molecular farming, represents an advanced and innovative field within biotechnology that leverages genetically modified plants or animals for the production of pharmaceutical compounds. This emerging approach to drug manufacturing utilizes the inherent biological mechanisms of living organisms to synthesize complex therapeutic molecules. Compared to conventional production methods, molecular pharming offers the potential for enhanced cost efficiency and scalability. Through the application of genetic engineering, specific genes can be introduced into plants or animals to enable the biosynthesis of therapeutic proteins, biopharmaceuticals, and vaccines.

List of Prominent Players in the Molecular Pharming Market:
• Leaf Expression Systems
• ORF Genetics hf.
• Agrenvec S.L.
• PlantForm
• Protalix Biotherapeutics
• Kbio, Inc.
• Cape Biologix Technologies (Cape Bio Pharm
• Bright Biotech
• Moolec Science SA
• Miruku
• Tiamat Sciences Corp.
• IngredientWerks
• Core Biogenesis
• Diamante Società Benefit S.r.l.
• Elo Life Systems

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Recent Developments:
• In April 2024, Nobell Foods, a molecular farming firm that makes animal-free cheese with soy-derived casein proteins, rebranded as Alpine Bio and received a new dairy protein patent. The San Francisco-based firm will now function as a subsidiary under the new name, Alpine Bio, and its scope has been broadened to include 15 proteins that may be produced in diverse plants using molecular farming.
• In October 2023, Moolec Science, which specializes in plant-based animal protein manufacturing via molecular pharming, raised $30 million from investors using convertible notes. The money will help the firm focus on expanding its research and development activities in more meat compounds and proteins. Moolec Science intends to include meat proteins into the matrix of soy and pea proteins, as opposed to standard ways of extracting and purifying animal proteins from their sources.
• In September 2023, Bio Better, a Food Technology business, opened its first food-grade pilot plant in northern Israel to speed up the production of growth factors for meat production. Using tobacco plants as self-sustaining bioreactors, the business aims to produce 100kg per day and hopes to increase to 5 tons by 2025, lowering industry costs.

Molecular Pharming Market Dynamics:
Market Drivers: Increased Investment in Bio-Pharming Research
The growing focus on bio-pharming research is expected to significantly boost the adoption of molecular pharming across the pharmaceutical and biotechnology sectors. Molecular pharming, also known as bio-pharming, involves the use of genetically modified plants or animals for the production of therapeutic proteins, vaccines, and other biopharmaceuticals.

Ongoing advancements in gene-editing technologies-particularly CRISPR/Cas9-are enabling more precise modification of host organisms, resulting in improved product yields and quality. These technological improvements are anticipated to enhance manufacturing efficiency and reduce production costs, thereby making molecular pharming an increasingly attractive option for biopharmaceutical companies. Furthermore, researchers are expanding the range of potential host organisms, exploring algae, fungi, and insects as viable alternatives for molecular production platforms.

Market Challenges: Elevated Development and Scale-Up Costs
Despite its numerous advantages, the growth of the molecular pharming market is hindered by the high costs associated with early-stage development and large-scale production. While molecular pharming offers scalability, flexibility, and the potential for cost savings in the long term, the initial investment required for research, development, and industrial-scale deployment remains substantial. These financial barriers may limit broader adoption, especially among emerging market players and small-to-mid-sized biopharmaceutical firms.

Regional Outlook: North America Projected to Register the Highest CAGR
North America is anticipated to lead the global molecular pharming market with the highest compound annual growth rate (CAGR) during the forecast period. This growth is primarily driven by the region's advanced biopharmaceutical industry, which is characterized by robust R&D initiatives and technological innovation. The presence of major market players and research institutions has significantly contributed to regional market expansion.

Additionally, the rising prevalence of chronic diseases, coupled with increasing demand for affordable therapeutic solutions, is further propelling the adoption of molecular pharming in the region. North America also benefits from a well-established supply chain infrastructure and a strong distribution network, which facilitate timely access to molecular pharming products. Supportive healthcare expenditure and reimbursement frameworks further enhance the accessibility and affordability of these advanced therapeutics, fostering sustained market growth.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1712

Segmentation of Molecular Pharming Market-
By Technology-
• Gene Gun
• Agro infiltration
• Electroporation
• Agrobacterium-Mediated Gene Transfer
• Others
By Application-
• Recombinant Antibodies
• Hormones
• Vaccines
• Industrial Enzymes
• Proteins & Protein-Based Materials
• Technical Reagents
• Nutritional Products
• Others
By Crop Source
• Maize
• Barley
• Tobacco
• Safflower
• Rice
• Alfalfa
By End-User
• Biotechnology & Pharmaceutical Companies
• Contract Manufacturing Organizations
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/molecular-pharming-market/1712

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.